<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945516</url>
  </required_header>
  <id_info>
    <org_study_id>2009-0233</org_study_id>
    <nct_id>NCT00945516</nct_id>
  </id_info>
  <brief_title>Newly Designed Fully Covered Metal Stent for the Benign Biliary Stricture</brief_title>
  <official_title>Newly Designed Fully Covered Metal Stent for the Benign Biliary Stricture: Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the feasibility, easy removability, safety, and
      migration rate of flared end fully covered self-expanding metal stent (FCSEMS) and anchoring
      FCSEMS for benign biliary stricture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Benign biliary strictures (BBS) are usually managed with plastic stents, whereas placement of
      uncovered metallic stents has been associated with failure related to mucosal hyperplasia.
      Fully covered self-expanding metal stent(FCSEMS) placement was reported as a useful method
      for BBS. However, stent migration was a frequent complication of CSEMS placement. Recently,
      flared end FCSEMS was developed to decrease stent migration, and anchoring CSEMS was newly
      developed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stent migration rate</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feasibility (Technical success rate and functional success rate)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Procedure related early complications occurred within one month and late complications occurred one month after the procedure)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Removability</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bile Duct Disease</condition>
  <arm_group>
    <arm_group_label>Flared end FCSEMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flared end FCSEMS will be inserted for the benign bile duct stricture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anchoring FCSEMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anchoring FCSEMS will be inserted for benign bile duct stricture</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bona stent速 (Flared end FCSEMS)</intervention_name>
    <description>Flared end FCSEMS for benign bile duct stricture will be inserted with ERCP.</description>
    <arm_group_label>Flared end FCSEMS</arm_group_label>
    <other_name>Bona stent速 (Sewoon medical Co., LTD., Seoul, Korea)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hanarostent速 (Anchoring FCSEMS)</intervention_name>
    <description>Anchoring FCSEMS for benign bile duct stricture will be inserted with ERCP.</description>
    <arm_group_label>Anchoring FCSEMS</arm_group_label>
    <other_name>Hanarostent速 (M.I.Tech, Seoul, Korea)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 years old

          -  Patient with benign bile duct stricture

        Exclusion Criteria:

          -  No written informed consent

          -  Malignant biliary obstruction

          -  Patients with uncorrectable severe coagulopathy

          -  Patients with severe cardiopulmonary disease precluding sedation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Do Hyun Park, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <last_update_submitted>October 18, 2010</last_update_submitted>
  <last_update_submitted_qc>October 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jung Sin Lee / the director of a center</name_title>
    <organization>Asan Medical Center</organization>
  </responsible_party>
  <keyword>Metal stent</keyword>
  <keyword>Bile duct stricture</keyword>
  <keyword>Stent migration</keyword>
  <keyword>Feasibility</keyword>
  <keyword>Safety</keyword>
  <keyword>Removability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

